Ascites Market Research Report - Global Forecast till 2027

Global Ascites Market: Information by Types (Transudative Ascites and Exudate Ascites), Diagnosis (Ultrasound, CT Scan, Laparoscopy and Angiography), Treatment (Surgeries), End Users (Hospitals & Clinics, Ambulatory Surgical Center and Diagnostic Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/1377-CR | August 2019 | Region: Global | 130 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data and TOC.

The Global Ascites Market is expected to register a CAGR of 4.0%and is anticipated to reach USD 2,832.5 million by 2023. Ascites is an abnormal accumulation fluid in the abdominal cavity. Liver cirrhosis is the most common cause of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume higher than 1.5 l ascites. For a smaller amount of fluid ultrasound, and CT scan are preferred


The rising prevalence of cirrhosis, improvement in reimbursement policies, and increasing occurrence of cancer are the major drivers propelling market growth. However, the complications associated with the ascites treatment constrain the growth of the market.


Market Dynamics


The rising prevalence of cirrhosis is expected to drive the growth of the market. For instance, according to a study published in the Canadian Journal of Gastroenterology and Hepatology in 2016, Cirrhotic ascites accounts for more than 75% of patients who are admitted to hospital with ascites. Moreover, liver cirrhosis is also found to be prevalent in the European region. Owing to the increasing alcohol consumption and obesity, liver cirrhosis is the third most common cause of premature mortality in the UK as compared to other countries in Western Europe, suggested by a study published in BMJ Open in 2017. Ascites is the most common complication of cirrhosis that leads to hospitalization and use of healthcare resources, thus increasing the prevalence of cirrhosis is expected to propel the ascites market during the forecast period.


Global Ascites Market Size, by End User, 2016 (USD Million)  Ascites Market


  Source: MRFR Analysis


Segmentation


The global ascites market has been segmented into types, diagnosis, treatment, and end-users. By types, the market has been segmented into transudative ascites and exudate ascites. Based on the diagnosis, the market has been segmented into ultrasound, CT scan, laparoscopy, and angiography. By treatment, the market has been segmented into surgeries. On the basis of end-users, the market has been segmented into hospitals & clinics, ambulatory surgical center, and diagnostic centers. The hospitals & clinics segment accounted for a market value of USD 838.4 million in 2016.


Key Players


The prominent players in the global ascites market are Sequana Medical NV (Switzerland), BioVie Inc. (US), PharmaCyte Biotech Inc. (US), Fresenius SE & Co. KGaA (Germany), BD (US), GI Supply (US), and Medtronic (Ireland).


Some of the key strategies followed by the players operating in the global ascites market were innovation, product development, acquisition, and expansion.


Asia-Pacific Ascites Market Share, by Country, 2016 (%)  Ascites Market


Source: MRFR Analysis


Regional Analysis


The global ascites market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas accounts for the significant share of the market owing to the improvement in reimbursement policies, and high healthcare expenditure. Europe accounts for the second-largest market, which is followed by Asia-Pacific. Asia-Pacific is the fastest-growing ascites market due to the presence of enormous opportunities for the development of this market. However, the Middle East & Africa has the least share in the market owing to the presence of poor and slow developing countries, especially in the African region.


Key Updates



  • In December 2017, BioVie Inc. received FDA fast track designation for BIV201.



  • In December 2017, Fresenius SE & Co. KGaA opened an extension of its production plant in Mihla, Germany by investing USD 11.78 million.



  • In April 2017, BD acquired C R Bard Inc., for USD 24 billion to expand its portfolio of oncology and surgery segment.


Market Segmentation


Global Ascites Market, by Types



  • Transudative Ascites

  • Exudate Ascites


Global Ascites Market, by Diagnosis



  • Ultrasound

  • CT Scan

  • Laparoscopy

  • Angiography


Global Ascites Market, by Treatment



  • Surgeries


Global Ascites Market, by End Users



  • Introduction

  • Hospitals & Clinics

  • Ambulatory Surgical Center

  • Diagnostic Centers


Global Ascites Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America

      • Brazil

      • Colombia

      • Mexico

      • Rest of South America







  • Europe

    • Western Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • UAE

    • Saudi Arabia

    • Oman

    • Kuwait

    • Qatar

    • Rest of Middle East

    • Africa




Available Additional Customizations



  • Additional Companies

    • Sanofi Inc.

    • TriOn Pharma

    • General Electric

    • Mylan NV



  • Supply & Demand Analysis


Intended Audience



  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies



Frequently Asked Questions (FAQ) :

Ascites market projected to grow at approximately 4.0% CAGR during the assessment period (2017-2023).

The valuation of the global ascites market is estimated to increase to USD 2,832.5 MN by the end of 2023.

Increasing activities of new drugs development and technological improvements are major tailwinds pushing the growth of the global ascites market.

North America holds the largest share in the global ascites market, followed by Europe and the Asia Pacific, respectively.

BioVie Inc. (US), Fresenius SE & Co. KGaA (Germany), Sequana Medical NV (Switzerland), BD (US), Medtronic (Ireland), PharmaCyte Biotech Inc. (US), and GI Supply (US), are some of the top players operating in the global ascites market.

1 Report Prologue

2 Market Introduction

2.1 Research Objective 15

2.2 Assumptions & Limitations 15

2.2.1 Assumptions 15

2.2.2 Limitations 15

2.3 Market Structure 16

3 Research Methodology

3.1 Introduction 17

3.1.1 Primary Research Methodology 18

3.1.2 Secondary Research Methodology 19

3.1.3 Market Share Analysis 20

3.1.4 Trade Analysis 20

3.1.5 Market Pricing Approach 21

4 Market Dynamics

4.1 Introduction 22

4.2 Drivers 23

4.2.1 Rising Prevalence of Cirrhosis (Impact Weightage: 35%) 23

4.2.2 Improvement in Reimbursement Policies (Impact Weightage: 30%) 24

4.2.3 Increasing Occurrence of Cancer (Impact Weightage: 35%) 25

4.3 Restraints 26

4.3.1 Complications Associated with the Ascites Treatment 26

4.4 Opportunity 27

4.4.1 Development of Innovative Treatment Options 27

4.5 Macroeconomic Indicators 27

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 28

5.1.1 Bargaining Power of Suppliers 29

5.1.2 Bargaining Power of Buyers 29

5.1.3 Threat of New Entrants 29

5.1.4 Threat of Substitutes 29

5.1.5 Intensity of Rivalry 29

5.2 Value Chain Analysis: Global Ascites Market 30

5.2.1 R&D and Designing 30

5.2.2 Manufacturing 31

5.2.3 Distribution & Sales 31

5.2.4 Post-Sales Monitoring 31

5.3 Demand & Supply: Gap Analysis 32

5.4 Pricing Analysis 32

6 Global Ascites Market by Types

6.1 Introduction 33

6.2 Transudative Ascites 34

6.3 Exudate Ascites 35

7 Global Ascites Market by Diagnosis

7.1 Introduction 36

7.2 Ultrasound 37

7.3 CT scan 38

7.4 Laparoscopy 38

7.5 Angiography 39

8 Global Ascites Market by Treatment

8.1 Introduction 40

8.2 Surgeries 42

9 Global Ascites Market by End Users

9.1 Introduction 43

9.2 Hospitals & Clinics 44

9.3 Ambulatory Surgical Center 45

9.4 Diagnostic Centres 45

10 Global Ascites Market by Regions

10.1 Introduction 46

10.2 Americas 48

10.2.1 North America 51

10.2.1.1 US 53

10.2.1.2 Canada 55

10.2.2 South America 57

10.2.2.1 Brazil 59

10.2.2.2 Colombia 61

10.2.2.3 Mexico 63

10.2.2.4 Rest of South America 65

10.3 Europe 67

10.3.1 Western Europe 70

10.3.1.1 Germany 72

10.3.1.2 France 74

10.3.1.3 UK 76

10.3.1.4 Italy 78

10.3.1.5 Spain 80

10.3.1.6 Rest of Western Europe 82

10.3.2 Eastern Europe 84

10.4 Asia-Pacific 86

10.4.1 China 89

10.4.2 Japan 91

10.4.3 India 93

10.4.4 Australia 95

10.4.5 South Korea 97

10.4.6 Rest of Asia-Pacific 99

10.5 Middle East & Africa 101

10.5.1 Middle East 104

10.5.1.1 UAE 106

10.5.1.2 Saudi Arabia 108

10.5.1.3 Oman 110

10.5.1.4 Kuwait 112

10.5.1.5 Qatar 114

10.5.1.6 Rest of Middle East 116

10.5.2 Africa 118

11 Competitive Analysis

11.1 Sequana Medical 120

11.1.1 Company Overview 120

11.1.2 Financials 120

11.1.3 Products 120

11.1.4 Strategy 120

11.1.5 Key Developments 120

11.2 BioVie 121

11.2.1 Company Overview 121

11.2.2 Financials 121

11.2.3 Products 121

11.2.4 Strategy 121

11.2.5 Key Developments 121

11.3 PharmaCyte Biotech Inc. 122

11.3.1 Company Overview 122

11.3.2 Financials 122

11.3.3 Products 122

11.3.4 Strategy 122

11.3.5 Key Developments 122

11.4 Fresenius SE & Co. KGaA 123

11.4.1 Company Overview 123

11.4.2 Financials 123

11.4.3 Products 123

11.4.4 Strategy 123

11.4.5 Key Developments 123

11.5 BD 124

11.5.1 Company Overview 124

11.5.2 Financials 124

11.5.3 Products 124

11.5.4 Strategy 124

11.5.5 Key Developments 124

11.6 GI Supply 125

11.6.1 Company Overview 125

11.6.2 Financials 125

11.6.3 Products 125

11.6.4 Strategy 125

11.6.5 Key Developments 125

11.7 Medtronic 126

11.7.1 Company Overview 126

11.7.2 Financials 126

11.7.3 Products 126

11.7.4 Strategy 126

11.7.5 Key Developments 126

12 Conclusion 127

12.1 Key Findings 127

12.1.1 From CEO’s View Point 127

12 Appendix

13.1 Discussion Blue Print 128

13 List of Tables

TABLE 1 PRIMARY INTERVIEWS 18

TABLE 2 SAMPLE SIZE DETERMINATION OF END–USERS (HOSPITALS, CLINICS) 19

TABLE 3 GLOBAL ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 33

TABLE 4 GLOBAL ASCITES MARKET FOR TRANSUDATIVE ASCITES 2014–2023 (USD MILLION) 34

TABLE 5 GLOBAL ASCITES MARKET FOR EXUDATE ASCITES 2014–2023 (USD MILLION) 35

TABLE 6 GLOBAL ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 36

TABLE 7 GLOBAL ASCITES MARKET FOR ULTRASOUND 2014–2023 (USD MILLION) 37

TABLE 8 GLOBAL ASCITES MARKET FOR CT SCAN 2014–2023 (USD MILLION) 38

TABLE 9 GLOBAL ASCITES MARKET FOR LAPAROSCOPY 2014–2023 (USD MILLION) 38

TABLE 10 GLOBAL ASCITES MARKET FOR ANGIOGRAPHY 2014–2023 (USD MILLION) 39

TABLE 11 GLOBAL ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 41

TABLE 12 GLOBAL ASCITES MARKET FOR SURGERIES 2014–2023 (USD MILLION) 42

TABLE 13 GLOBAL ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 43

TABLE 14 GLOBAL ASCITES MARKET FOR HOSPITALS & CLINICS 2014–2023 (USD MILLION) 44

TABLE 15 GLOBAL ASCITES MARKET FOR AMBULATORY SURGICAL CENTER 2014–2023 (USD MILLION) 45

TABLE 16 GLOBAL ASCITES MARKET FOR DIAGNOSTIC CENTRES 2014–2023 (USD MILLION) 45

TABLE 17 GLOBAL ASCITES MARKET BY REGIONS 2014–2023 (USD MILLION) 46

TABLE 18 AMERICAS ASCITES MARKET BY REGIONS 2014–2023 (USD MILLION) 48

TABLE 19 AMERICAS ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 49

TABLE 20 AMERICAS ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 49

TABLE 21 AMERICAS ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 50

TABLE 22 AMERICAS ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 50

TABLE 23 NORTH AMERICA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 51

TABLE 24 NORTH AMERICA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 51

TABLE 25 NORTH AMERICA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 52

TABLE 26 NORTH AMERICA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 52

TABLE 27 US ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 53

TABLE 28 US ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 53

TABLE 29 US ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 54

TABLE 30 US ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 54

TABLE 31 CANADA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 55

TABLE 32 CANADA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 55

TABLE 33 CANADA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 56

TABLE 34 CANADA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 56

TABLE 35 SOUTH AMERICA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 57

TABLE 36 SOUTH AMERICA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 57

TABLE 37 SOUTH AMERICA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 58

TABLE 38 SOUTH AMERICA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 58

TABLE 39 BRAZIL ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 59

TABLE 40 BRAZIL ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 59

TABLE 41 BRAZIL ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 60

TABLE 42 BRAZIL ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 60

TABLE 43 COLOMBIA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 61

TABLE 44 COLOMBIA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 61

TABLE 45 COLOMBIA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 62

TABLE 46 COLOMBIA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 62

TABLE 47 MEXICO ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 63

TABLE 48 MEXICO ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 63

TABLE 49 MEXICO ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 64

TABLE 50 MEXICO ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 64

TABLE 51 REST OF SOUTH AMERICA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 65

TABLE 52 REST OF SOUTH AMERICA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 65

TABLE 53 REST OF SOUTH AMERICA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 66

TABLE 54 REST OF SOUTH AMERICA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 66

TABLE 55 EUROPE ASCITES MARKET BY REGIONS 2014–2023 (USD MILLION) 67

TABLE 56 EUROPE ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 68

TABLE 57 EUROPE ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 68

TABLE 58 EUROPE ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 69

TABLE 59 EUROPE ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 69

TABLE 60 WESTERN EUROPE ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 70

TABLE 61 WESTERN EUROPE ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 70

TABLE 62 WESTERN EUROPE ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 71

TABLE 63 WESTERN EUROPE ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 71

TABLE 64 GERMANY ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 72

TABLE 65 GERMANY ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 72

TABLE 66 GERMANY ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 73

TABLE 67 GERMANY ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 73

TABLE 68 FRANCE ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 74

TABLE 69 FRANCE ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 74

TABLE 70 FRANCE ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 75

TABLE 71 FRANCE ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 75

TABLE 72 UK ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 76

TABLE 73 UK ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 76

TABLE 74 UK ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 77

TABLE 75 UK ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 77

TABLE 76 ITALY ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 78

TABLE 77 ITALY ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 78

TABLE 78 ITALY ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 79

TABLE 79 ITALY ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 79

TABLE 80 SPAIN ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 80

TABLE 81 SPAIN ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 80

TABLE 82 SPAIN ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 81

TABLE 83 SPAIN ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 81

TABLE 84 REST OF WESTERN EUROPE ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 82

TABLE 85 REST OF WESTERN EUROPE ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 82

TABLE 86 REST OF WESTERN EUROPE ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 83

TABLE 87 REST OF WESTERN EUROPE ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 83

TABLE 88 EASTERN EUROPE ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 84

TABLE 89 EASTERN EUROPEASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 84

TABLE 90 EASTERN EUROPEASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 85

TABLE 91 EASTERN EUROPEASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 85

TABLE 92 ASIA-PACIFIC ASCITES MARKET BY REGIONS 2014–2023 (USD MILLION) 86

TABLE 93 ASIA-PACIFIC ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 87

TABLE 94 ASIA-PACIFIC ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 87

TABLE 95 ASIA-PACIFIC ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 88

TABLE 96 ASIA-PACIFIC ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 88

TABLE 97 CHINA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 89

TABLE 98 CHINA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 89

TABLE 99 CHINA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 90

TABLE 100 CHINA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 90

TABLE 101 JAPAN ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 91

TABLE 102 JAPAN ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 91

TABLE 103 JAPAN ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 92

TABLE 104 JAPAN ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 92

TABLE 105 INDIA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 93

TABLE 106 INDIA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 93

TABLE 107 INDIA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 94

TABLE 108 INDIA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 94

TABLE 109 AUSTRALIA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 95

TABLE 110 AUSTRALIA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 95

TABLE 111 AUSTRALIA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 96

TABLE 112 AUSTRALIA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 96

TABLE 113 SOUTH KOREA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 97

TABLE 114 SOUTH KOREA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 97

TABLE 115 SOUTH KOREA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 98

TABLE 116 SOUTH KOREA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 98

TABLE 117 REST OF ASIA-PACIFIC ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 99

TABLE 118 REST OF ASIA-PACIFIC ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 99

TABLE 119 REST OF ASIA-PACIFIC ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 100

TABLE 120 REST OF ASIA-PACIFIC ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 100

TABLE 121 MIDDLE EAST & AFRICA ASCITES MARKET BY REGIONS 2014–2023 (USD MILLION) 101

TABLE 122 MIDDLE EAST & AFRICA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 102

TABLE 123 MIDDLE EAST & AFRICA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 102

TABLE 124 MIDDLE EAST & AFRICA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 103

TABLE 125 MIDDLE EAST & AFRICA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 103

TABLE 126 MIDDLE EAST ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 104

TABLE 127 MIDDLE EAST ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 104

TABLE 128 MIDDLE EAST ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 105

TABLE 129 MIDDLE EAST ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 105

TABLE 130 UAE ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 106

TABLE 131 UAE ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 106

TABLE 132 UAE ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 107

TABLE 133 UAE ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 107

TABLE 134 SAUDI ARABIA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 108

TABLE 135 SAUDI ARABIA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 108

TABLE 136 SAUDI ARABIA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 109

TABLE 137 SAUDI ARABIA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 109

TABLE 138 OMAN ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 110

TABLE 139 OMAN ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 110

TABLE 140 OMAN ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 111

TABLE 141 OMAN ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 111

TABLE 142 KUWAIT ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 112

TABLE 143 KUWAIT ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 112

TABLE 144 KUWAIT ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 113

TABLE 145 KUWAIT ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 113

TABLE 146 QATAR ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 114

TABLE 147 QATAR ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 114

TABLE 148 QATAR ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 115

TABLE 149 QATAR ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 115

TABLE 150 REST OF MIDDLE EAST ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 116

TABLE 151 REST OF MIDDLE EAST ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 116

TABLE 152 REST OF MIDDLE EAST ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 117

TABLE 153 REST OF MIDDLE EAST ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 117

TABLE 154 AFRICA ASCITES MARKET BY TYPES 2014–2023 (USD MILLION) 118

TABLE 155 AFRICA ASCITES MARKET BY DIAGNOSIS 2014–2023 (USD MILLION) 118

TABLE 156 AFRICA ASCITES MARKET BY TREATMENT 2014–2023 (USD MILLION) 119

TABLE 157 AFRICA ASCITES MARKET BY END USERS 2014–2023 (USD MILLION) 119

14 List of Figures

FIGURE 1 GLOBAL ASCITES MARKET BY TYPE, 2016 (%) 14

FIGURE 2 GLOBAL ASCITES MARKET, BY DIAGNOSIS, 2016 (%) 14

FIGURE 3 RESEARCH METHODOLOGY 17

FIGURE 4 FIGURE 1 VALUE CHAIN: GLOBAL ASCITES MARKET 30

FIGURE 5 GLOBAL ASCITES MARKET BY TYPES 2016 & 2023 (USD MILLION) 34

FIGURE 6 GLOBAL ASCITES MARKET BY DIAGNOSIS 2016 & 2023 (USD MILLION) 37

FIGURE 7 GLOBAL ASCITES MARKET BY TREATMENT 2016 & 2023 (USD MILLION) 41

FIGURE 8 GLOBAL ASCITES MARKET BY END USERS 2016 & 2023 (USD MILLION) 44

FIGURE 9 GLOBAL ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 47

FIGURE 10 AMERICAS ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 48

FIGURE 11 EUROPE ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 67

FIGURE 12 ASIA-PACIFIC ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 86

FIGURE 13 MIDDLE EAST & AFRICA ASCITES MARKET BY REGIONS MARKET SHARE 2016 (%) 101